A high risk of developing insulin resistance (IR) and, eventually, type 2 diabetes mellitus
(T2DM) is associated with chronic hepatitis C virus (HCV). Multiple mechanisms can account …

Background The interplay between HCV, DM, and DAA therapy is poorly understood. We
compared HCV infection characteristics, treatment uptake, and treatment outcomes in …

Background A burden of data suggests that insulin signaling could be impaired with
hepatitis C virus infection, and this boost the onset of type 2 diabetes mellitus beyond and in …

Background The association between hepatitis C virus (HCV), insulin resistance (IR), and
metabolic syndrome has been extensively investigated. Direct-acting antivirals (DAAs) have …

Background: HCV and DM are chronic diseases of high global prevalence. Many studies
proved the association between Hepatitis C and DM in the last three decades and this …

Introduction: Chronic HCV infection has been implicated as a risk factor for new onset
diabetes mellitus type II and worsening of glycemic control in patients with already …

Background: Treatment of chronic hepatitis C (CHC) with direct acting antivirals (DAAS)
improves the rates of sustained virological response (SVR). However, derangements with …

Background: Hepatitis C virus (HCV) infection is considered to increase the possibility of
incidental type 2 diabetes mellitus (Type 2 DM) in prone subjects, independent to the stage …

Background: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease.
Chronic HCV infection is associated with development of insulin resistance and therefore …

Background: Infection with the hepatitis C virus is a public health problem due to its
prevalence, morbidity and mortality. Inspite high rate of SVR to treatment by DAAS, still …